Reventus Overview

  • Year Founded
  • 2023

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 1

Reventus General Information

Description

Developer of small-molecule therapeutics intended for the treatment of rare mitochondrial diseases through drug repositioning. The company applies a development model that identifies shelved or discontinued compounds with existing safety and pharmacokinetic data, conducts non-clinical validation, defines regulatory and clinical pathways, manages intellectual property strategy, and advances selected assets through preclinical and early clinical stages, enabling rare disease stakeholders, clinicians, and regulators to access therapies with reduced early-stage risk, shorter development timelines, and clearer routes toward clinical proof of efficacy.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • I-Factory
  • 12 Rue De La Part-dieu
  • 69003 Lyon
  • France
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • I-Factory
  • 12 Rue De La Part-dieu
  • 69003 Lyon
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Reventus Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 01-Jan-2026 Completed Pre-Clinical Trials
To view Reventus’s complete valuation and funding history, request access »

Reventus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Pulsalys Accelerator/Incubator Minority
To view Reventus’s complete investors history, request access »

Reventus FAQs

  • When was Reventus founded?

    Reventus was founded in 2023.

  • Where is Reventus headquartered?

    Reventus is headquartered in Lyon, France.

  • What industry is Reventus in?

    Reventus’s primary industry is Drug Discovery.

  • Is Reventus a private or public company?

    Reventus is a Private company.

  • What is Reventus’s current revenue?

    The current revenue for Reventus is .

  • Who are Reventus’s investors?

    Pulsalys has invested in Reventus.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process